NCT07466589 Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)
| NCT ID | NCT07466589 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vivonics, Inc. |
| Condition | Mild Traumatic Brain Injury, Concussion |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2025-08-22 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2025-08-22 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain injury (mTBI).
Eligibility Criteria
Inclusion Criteria: 1. Age 18-55 2. Diagnosed with concussion, evaluated at the University of Michigan 3. Symptoms persistent greater than 4-6 weeks 4. Self-reported imbalance 5. Must be able to attend in-person session. No racial/ethnic groups will be excluded, although all participants must be fluent speakers of English. Exclusion Criteria: 1. Anyone under the age of 18 or over the age of 55 2. Presence of prior diagnosis of peripheral vestibulopathy 3. Women who are pregnant 4. Inability to complete testing (e.g., severe symptom burden, inability to stand unassisted).
Contact & Investigator
Devin L McCaslin, PhD
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT07466589 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Mild Traumatic Brain Injury, Concussion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07466589 currently recruiting?
Yes, NCT07466589 is actively recruiting participants. Contact the research team at jcolls@vivonics.com for enrollment information.
Where is the NCT07466589 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT07466589 clinical trial?
NCT07466589 is sponsored by Vivonics, Inc.. The principal investigator is Devin L McCaslin, PhD at University of Michigan. The trial plans to enroll 32 participants.